Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions

Breast cancer chemoprevention with selective estrogen receptor modulators (SERM) or aromatase inhibitors (AI) remains underutilized among high-risk women. A potential barrier to chemoprevention is competing comorbidities such as atherosclerotic cardiovascular disease (ASCVD), due to concern for addi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer prevention research (Philadelphia, Pa.) Pa.), 2023-12, Vol.16 (12), p.661-667
Hauptverfasser:	Lawal, Kehinde O, Nilan, Luisa, Amenta, Jacquelyn, McGuinness, Julia E, Kukafka, Rita, Crew, Katherine D
Format:	Artikel
Sprache:	eng
Schlagworte:	Atherosclerosis Breast Carcinoma In Situ - drug therapy Breast Neoplasms - drug therapy Breast Neoplasms - epidemiology Breast Neoplasms - prevention & control Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Chemoprevention Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Middle Aged Retrospective Studies Selective Estrogen Receptor Modulators - therapeutic use United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!